7-159032034-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_003382.5(VIPR2):c.1005G>A(p.Pro335Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00634 in 1,614,058 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0036 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0066 ( 47 hom. )
Consequence
VIPR2
NM_003382.5 synonymous
NM_003382.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -7.20
Genes affected
VIPR2 (HGNC:12695): (vasoactive intestinal peptide receptor 2) This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 7-159032034-C-T is Benign according to our data. Variant chr7-159032034-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 710208.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-7.2 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VIPR2 | NM_003382.5 | c.1005G>A | p.Pro335Pro | synonymous_variant | 11/13 | ENST00000262178.7 | NP_003373.2 | |
VIPR2 | NM_001308259.1 | c.957G>A | p.Pro319Pro | synonymous_variant | 8/10 | NP_001295188.1 | ||
VIPR2 | NM_001304522.2 | c.765G>A | p.Pro255Pro | synonymous_variant | 9/11 | NP_001291451.1 | ||
VIPR2 | NR_130758.2 | n.1101G>A | non_coding_transcript_exon_variant | 11/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VIPR2 | ENST00000262178.7 | c.1005G>A | p.Pro335Pro | synonymous_variant | 11/13 | 1 | NM_003382.5 | ENSP00000262178.2 | ||
VIPR2 | ENST00000402066.5 | c.1428G>A | p.Pro476Pro | synonymous_variant | 11/13 | 5 | ENSP00000384497.1 | |||
VIPR2 | ENST00000377633.7 | c.957G>A | p.Pro319Pro | synonymous_variant | 8/10 | 2 | ENSP00000366860.3 |
Frequencies
GnomAD3 genomes AF: 0.00364 AC: 554AN: 152162Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
554
AN:
152162
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00391 AC: 981AN: 251146Hom.: 6 AF XY: 0.00408 AC XY: 554AN XY: 135842
GnomAD3 exomes
AF:
AC:
981
AN:
251146
Hom.:
AF XY:
AC XY:
554
AN XY:
135842
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00662 AC: 9675AN: 1461778Hom.: 47 Cov.: 32 AF XY: 0.00651 AC XY: 4731AN XY: 727182
GnomAD4 exome
AF:
AC:
9675
AN:
1461778
Hom.:
Cov.:
32
AF XY:
AC XY:
4731
AN XY:
727182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00364 AC: 554AN: 152280Hom.: 3 Cov.: 33 AF XY: 0.00321 AC XY: 239AN XY: 74464
GnomAD4 genome
AF:
AC:
554
AN:
152280
Hom.:
Cov.:
33
AF XY:
AC XY:
239
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 13, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | VIPR2: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at